Identification of Novel Gene Signatures using Next-Generation Sequencing Data from COVID-19 Infection Models: Focus on Neuro-COVID and Potential Therapeutics

Identification of Novel Gene Signatures using Next-Generation Sequencing Data from COVID-19 Infection Models: Focus on Neuro-COVID and Potential Therapeutics

SARS-CoV-2 is the causative agent for coronavirus disease-19 (COVID-19) and belongs to the family Coronaviridae that causes sickness varying from the common cold to more severe illnesses such as severe acute respiratory syndrome, sudden stroke, neurological complications (Neuro-COVID), multiple orga...

Full description

Bibliographic Details
Main Authors: Peter Natesan Pushparaj, Angham Abdulrahman Abdulkareem, Muhammad Imran Naseer
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Pharmacology
Subjects:
SARS-CoV-2
COVID-19
Neuro-COVID
bronchial epithelium
cerebrospinal fluid
RNA sequencing
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.688227/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.688227/full

Similar Items